Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTARES: Alirocumab + Rosuvastatin vs Rosuvastatin Alone on Coronary Lipid Core Plaques by NIRS-IVUS
jRCT1051180064Completed
- Start
- Apr 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial in coronary arteriosclerosis, acute coronary syndrome (ACS), myocardial infarction (MI) and 2 more comparing Alirocumab + rosuvastatin with Rosuvastatin-based standard-of-care (2 arms). Primary endpoint: Change in maxLCBI(4mm). Started Apr 2018; status: completed.
02
Drugs
alirocumab
03
Conditions
coronary arteriosclerosisacute coronary syndrome (ACS)myocardial infarction (MI)unstable anginastable angina
Beyond the preview
Go deeper on jRCT1051180064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051180064.